Vir Bio Identifies 2 Antibodies That Might Stop Coronavirus

Vir Biotechnology (NASDAQ: VIR) announced Wednesday morning that its researchers have identified two monoclonal antibodies (mAbs) that bind to the SARS-CoV-2 spike protein found on the surface of the coronavirus that the World Health Organization officially named COVID-19 this week.